Choroidal neovascularization in the rat induced by adenovirus mediated expression of vascular endothelial growth factor.

PURPOSE To determine the effects of an adenovirus vector encoding vascular endothelial growth factor(165) (Ad.VEGF) delivered to the subretinal space in the rat. METHODS An E1-deleted adenoviral vector encoding VEGF was injected into the subretinal space of Long-Evans rats. Immunohistochemistry identified VEGF expression. Histopathologic changes in the retina were determined by light and electron microscopy, immunohistochemistry, fluorescein angiography, and examination of wholemounts of choroid and retina. RESULTS Increased expression of VEGF only in the retinal pigment epithelium (RPE) was detected after Ad.VEGF injection. Histopathology of these eyes revealed minimal subretinal exudation at 1 week followed by the appearance of vascular structures in the subretinal space by week 2, which persisted up to 4 weeks. Shortening of photoreceptor outer segments and reduction of the outer nuclear layer were present overlying areas of neovascularization. Fluorescein angiography of animals injected with fluorescein-dextran revealed a deep complex of new vessels. Choroidal flatmounts showed new vessel formation, verified by detection of endothelial cells via immunohistochemistry, arising from the choroid with absence of change in the overlying retinal vasculature. Electron microscopy confirmed the presence of sub-RPE endothelial cells and pericytes and the loss of integrity of Bruch's membrane, and serial sectioning demonstrated choroidal vascular growth through Bruch's membrane. CONCLUSIONS These results support the hypothesis that overexpression of VEGF from RPE cells is capable of inducing choroidal neovascularization in the rat and provide a framework for further examining angiogenic processes in the RPE-choroid complex.

[1]  T. Ishibashi,et al.  Morphologic observations on experimental subretinal neovascularization in the monkey. , 1987, Investigative ophthalmology & visual science.

[2]  J. Bennett,et al.  Adenovirus-mediated delivery of rhodopsin-promoted bcl-2 results in a delay in photoreceptor cell death in the rd/rd mouse , 1998, Gene Therapy.

[3]  E. Adamson,et al.  Down-regulation of epidermal growth factor receptors in mouse embryos. , 1982, Developmental biology.

[4]  K. Nakagawa,et al.  The relation between expression of vascular endothelial growth factor and breakdown of the blood-retinal barrier in diabetic rat retinas. , 1996, Laboratory investigation; a journal of technical methods and pathology.

[5]  T. Veikkola,et al.  VEGFs, receptors and angiogenesis. , 1999, Seminars in cancer biology.

[6]  E. Rodriguez-Boulan,et al.  Phagocytosis of rod outer segments by retinal pigment epithelial cells requires αvβ5 integrin for binding but not for internalization , 1997 .

[7]  L. Aiello,et al.  Vascular endothelial growth factor-induced retinal permeability is mediated by protein kinase C in vivo and suppressed by an orally effective beta-isoform-selective inhibitor. , 1998, Diabetes.

[8]  S. Seregard,et al.  Subfoveal fibrovascular membranes in age-related macular degeneration express vascular endothelial growth factor. , 1996, Investigative ophthalmology & visual science.

[9]  C. Puliafito,et al.  A new model of experimental choroidal neovascularization in the rat. , 1989, Archives of ophthalmology.

[10]  K. Csaky,et al.  Saturation of, and competition for entry into, the apical secretory pathway. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[11]  K. Csaky,et al.  Recombinant adenovirus-mediated gene transfer into the adult rat retina. , 1998, Current eye research.

[12]  P. D. de Jong,et al.  Increased expression of angiogenic growth factors in age-related maculopathy , 1997, The British journal of ophthalmology.

[13]  Hanns Lochmüller,et al.  Emergence of early region 1-containing replication-competent adenovirus in stocks of replication-defective adenovirus recombinants (delta E1 + delta E3) during multiple passages in 293 cells. , 1994, Human gene therapy.

[14]  H. Blau,et al.  VEGF gene delivery to muscle: potential role for vasculogenesis in adults. , 1998, Molecular cell.

[15]  R. Crystal,et al.  Regional angiogenesis induced in nonischemic tissue by an adenoviral vector expressing vascular endothelial growth factor. , 1997, Human gene therapy.

[16]  F. Ferris,et al.  Age-related macular degeneration and blindness due to neovascular maculopathy. , 1984, Archives of ophthalmology.

[17]  H. Hurst,et al.  Suicide gene expression induced in tumour cells transduced with recombinant adenoviral, retroviral and plasmid vectors containing the ERBB2 promoter. , 1996, Gene therapy.

[18]  P. Campochiaro,et al.  Intravitreal sustained release of VEGF causes retinal neovascularization in rabbits and breakdown of the blood-retinal barrier in rabbits and primates. , 1998, Experimental eye research.

[19]  Hanns Lochmüller,et al.  Emergence of Early Region 1-Containing Replication-Competent Adenovirus in Stocks of Replication-Defective Adenovirus Recombinants (ΔE1 + ΔE3) During Multiple Passages in 293 Cells , 1994 .

[20]  R. Crystal,et al.  Salvage angiogenesis induced by adenovirus-mediated gene transfer of vascular endothelial growth factor protects against ischemic vascular occlusion. , 1998, Journal of vascular surgery.

[21]  R. Worton,et al.  Modulation of the specificity and activity of a cellular promoter in an adenoviral vector. , 1997, Human gene therapy.

[22]  A. Passaniti,et al.  VEGF165 expressed by a replication-deficient recombinant adenovirus vector induces angiogenesis in vivo. , 1995, Circulation research.

[23]  E. Adamson,et al.  Functional EGF receptors are present on mouse embryo tissues , 1981, Nature.

[24]  J. Whitsett,et al.  Persistence of replication-deficient adenovirus-mediated gene transfer in lungs of immune-deficient (nu/nu) mice. , 1995, Human gene therapy.

[25]  P. Campochiaro,et al.  Evolution of neovascularization in mice with overexpression of vascular endothelial growth factor in photoreceptors. , 1998, Investigative ophthalmology & visual science.

[26]  H. Kaplan,et al.  Distribution of growth factors in subfoveal neovascular membranes in age-related macular degeneration and presumed ocular histoplasmosis syndrome. , 1995, American journal of ophthalmology.

[27]  I. Constable,et al.  Generation and characterization of a recombinant adenovirus expressing vascular endothelial growth factor for studies of neovascularization in the eye. , 1999, Australian and New Zealand journal of ophthalmology.

[28]  P. Campochiaro,et al.  Transgenic mice with increased expression of vascular endothelial growth factor in the retina: a new model of intraretinal and subretinal neovascularization. , 1997, The American journal of pathology.

[29]  N. Bressler,et al.  Clinicopathologic Correlation of Occult Choroidal Neovascularization in Age-Related Macular Degeneration , 1992, Archives of ophthalmology.

[30]  T. Ishibashi,et al.  Pathogenesis of laser-induced choroidal subretinal neovascularization. , 1990, Investigative ophthalmology & visual science.

[31]  Thomas N. Sato,et al.  Increased vascularization in mice overexpressing angiopoietin-1. , 1998, Science.

[32]  D. Hinton,et al.  Transdifferentiated retinal pigment epithelial cells are immunoreactive for vascular endothelial growth factor in surgically excised age-related macular degeneration-related choroidal neovascular membranes. , 1996, Investigative ophthalmology & visual science.

[33]  K. Nakagawa,et al.  The temporal and spatial vascular endothelial growth factor expression in retinal vasculogenesis of rat neonates. , 1996, Laboratory investigation; a journal of technical methods and pathology.

[34]  A Kijlstra,et al.  Polarized vascular endothelial growth factor secretion by human retinal pigment epithelium and localization of vascular endothelial growth factor receptors on the inner choriocapillaris. Evidence for a trophic paracrine relation. , 1999, American Journal of Pathology.

[35]  Hidehiro Ishii,et al.  Vascular Endothelial Growth Factor–Induced Retinal Permeability Is Mediated by Protein Kinase C In Vivo and Suppressed by an Orally Effective β-Isoform–Selective Inhibitor , 1997, Diabetes.

[36]  L. Aiello,et al.  Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. , 1994, The New England journal of medicine.

[37]  J. Bennett,et al.  Adenovirus vector-mediated in vivo gene transfer into adult murine retina. , 1994, Investigative ophthalmology & visual science.

[38]  R. Frank,et al.  Growth factor localization in choroidal neovascular membranes of age-related macular degeneration. , 1994, Investigative ophthalmology & visual science.

[39]  M. Killingsworth,et al.  Morphology of early choroidal neovascularisation in age-related macular degeneration: Correlation with activity , 1997, Eye.

[40]  Ivana K. Kim,et al.  Constitutive expression of VEGF, VEGFR-1, and VEGFR-2 in normal eyes. , 1999, Investigative ophthalmology & visual science.

[41]  K. Csaky,et al.  Apical Polarity of N-CAM and EMMPRIN in Retinal Pigment Epithelium Resulting from Suppression of Basolateral Signal Recognition , 1998, The Journal of cell biology.

[42]  H. Takagi,et al.  Expressions of Angiopoietins and Tie2 in Human Choroidal Neovascular Membranes , 2022 .

[43]  Y. Fukuda,et al.  Adenovirus vector-mediated gene transfer into rat retinal neurons and Müller cells in vitro and in vivo , 1998, Neuroscience Letters.

[44]  Matthew A. Thomas,et al.  CLINICOPATHOLOGIC STUDIES OF AN EYE AFTER SUBMACULAR MEMBRANECTOMY FOR CHOROIDAL NEOVASCULARIZATION , 1995, Retina.

[45]  P. Stewart,et al.  Structure of Adenovirus Complexed with Its Internalization Receptor, αvβ5 Integrin , 1999, Journal of Virology.

[46]  R. Frank,et al.  A model of subretinal neovascularization in the pigmented rat. , 1989, Current eye research.

[47]  B. Davidson,et al.  In vivo transfer of a reporter gene to the retina mediated by an adenoviral vector. , 1994, Investigative ophthalmology & visual science.

[48]  Y. Goto,et al.  A vitrectomy improves the transfection efficiency of adenoviral vector-mediated gene transfer to Müller cells , 1998, Gene Therapy.

[49]  Joan W. Miller,et al.  Cloning and mRNA expression of vascular endothelial growth factor in ischemic retinas of Macaca fascicularis. , 1996, Investigative ophthalmology & visual science.

[50]  S. Coleman,et al.  Inhibition of mouse mammary ductal morphogenesis and down-regulation of the EGF receptor by epidermal growth factor. , 1990, Developmental biology.

[51]  L. Yannuzzi,et al.  CLINICOPATHOLOGIC CORRELATION OF CHOROIDAL NEOVASCULARIZATION DEMONSTRATED BY INDOCYANINE GREEN ANGIOGRAPHY IN A PATIENT WITH RETENTION OF GOOD VISION FOR ALMOST FOUR YEARS , 1994, Retina.

[52]  D. Eliott,et al.  Basic fibroblast growth factor and vascular endothelial growth factor are present in epiretinal and choroidal neovascular membranes. , 1996, American journal of ophthalmology.

[53]  H Ueno,et al.  Retinal functional change caused by adenoviral vector-mediated transfection of LacZ gene. , 1998, Human gene therapy.

[54]  Joan W. Miller,et al.  Vascular endothelial growth factor/vascular permeability factor is temporally and spatially correlated with ocular angiogenesis in a primate model. , 1994, The American journal of pathology.

[55]  R. D'Amato,et al.  Microscopic visualization of the retina by angiography with high-molecular-weight fluorescein-labeled dextrans in the mouse. , 1993, Microvascular research.

[56]  G. Breier,et al.  The Vascular Endothelial Growth Factor Receptor Flt-1 Mediates Biological Activities , 1996, The Journal of Biological Chemistry.

[57]  M. Killingsworth,et al.  Macrophages related to Bruch's membrane in age-related macular degeneration , 1990, Eye.

[58]  B. Davidson,et al.  Phenotype correction in retinal pigment epithelium in murine mucopolysaccharidosis VII by adenovirus-mediated gene transfer. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[59]  Y. Ikada,et al.  Cellular response in subretinal neovascularization induced by bFGF-impregnated microspheres. , 1999, Investigative ophthalmology & visual science.

[60]  R. Crystal,et al.  Focal angiogen therapy using intramyocardial delivery of an adenovirus vector coding for vascular endothelial growth factor 121. , 2000, The Annals of thoracic surgery.

[61]  E. Rodriguez-Boulan,et al.  Phagocytosis of rod outer segments by retinal pigment epithelial cells requires alpha(v)beta5 integrin for binding but not for internalization. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[62]  P. Henkind,et al.  Ultrastructure of Bruch's membrane after krypton laser photocoagulation. I. Breakdown of Bruch's membrane. , 1986, Archives of ophthalmology.

[63]  W. Silverman,et al.  Patterns of brain angiogenesis after vascular endothelial growth factor administration in vitro and in vivo. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[64]  M. Klagsbrun,et al.  Vascular endothelial growth factor and its receptors. , 1996, Cytokine & growth factor reviews.

[65]  I. Constable,et al.  The use of adenovirus-mediated gene transfer to develop a rat model for photoreceptor degeneration. , 2000, Investigative ophthalmology & visual science.

[66]  Douglas Hanahan,et al.  Signaling Vascular Morphogenesis and Maintenance , 1997, Science.